Next, an assay was developed to measure indices of mitochondrial function. Oligomycin, FCCP, and antimycin A were injected sequentially through ports in the Seahorse Flux Pak cartridges to final concentrations of 1 μg/ml, 1 μM, and 10 μM, respectively. This allowed determination of the basal level of oxygen consumption, the amount of oxygen consumption linked to ATP production, the level of non-ATP linked oxygen consumption (proton leak), the maximal respiration capacity, and the non-mitochondrial oxygen consumption. As shown in
Electron Transport Complex III
This complex plays a central role in cellular respiration, catalyzing the oxidation of ubiquinol and the reduction of cytochrome c, thereby generating a proton gradient that drives ATP synthesis.
Reserach into the structure, function, and regulation of Electron Transport Complex III has implications for understanding energy metabolism, mitochondrial dysfunction, and various disease states.
PubCompare.ai's cutting-edge AI-driven protocol optimization can help navigaet the vast landscape of literature, pre-prints, and patents to uncover the best protocols and products for your Electron Transport Complex III reserach needs.
Most cited protocols related to «Electron Transport Complex III»
Several measures of mitochondrial respiration, including basal respiration, ATP-linked respiration, proton leak respiration and reserve capacity, were derived by the sequential addition of pharmacological agents to the respiring cells, as diagramed in
ECAR is primarily a measure of lactate production and can be equated to the glycolytic rate (i.e., glycolysis), and ECAR is measured simultaneously with OCR in the Seahorse assay. Basal ECAR refers to the ECAR measured before the injection of oligomycin. Glycolytic reserve capacity is calculated by subtracting the basal ECAR from the oligomycin-induced ECAR.
One hour prior to the assay, cells were seeded onto poly-D-lysine coated 96-well XF-PS plates at a density of 1.1×105 cells/well in DMEM XF assay media (unbuffered DMEM supplemented with 11 mM glucose, 2 mM L-glutamax, and 1 mM sodium pyruvate). Cells were plated with at least 4 replicate wells for each treatment group. Titrations were performed to determine the optimal concentrations of oligomycin (1.0 µM), FCCP (0.3 µM), antimycin A (0.3 µM) and rotenone (1.0 µM).
Most recents protocols related to «Electron Transport Complex III»
Example 8
GiNOX, a water-forming NADH oxidase derived from Giardia intestinalis, and mitoGiNOX are capable of restoring the proliferation of mammalian cells cultured in pyruvate-depleted media and in the presence of antimycin, a complex III inhibitor. HeLa Tet3G cells cultured in the presence of varying concentrations of pyruvate demonstrated a diminished pyruvate-dependency in the presence of antimycin when GiNOX and mitoGiNOX were expressed in these cells (
Oxygen consumption rate (OCR) analyses were performed in a Seahorse XFe24 extracellular flux analyzer (Agilent). Purified platelets were seeded (2.5 × 107 cells/well) in 100 µl of Seahorse medium (8.3 g/L DMEM, 1.85 g/L NaCl, 5 mM glucose, 1 mM pyruvate, 2 mM glutamine, 5 mM HEPES, pH 7.4) on XFe24 V7 cell culture plates (Agilent), and the plates centrifuged at 300 g for 10 min to attach the platelets to the bottom of the plate. PBMCs were seeded (4 × 105 cells/well in 100 µl of Seahorse medium) on poly-D-lysine coated XFe24 V7cell culture plates and incubated for 30 min at 37 °C to allow the adhesion to the plate. Seahorse medium (500 µl) was added to each well; plates were kept at 37 °C for approximately 1 h and loaded into the instrument.
Oxygen consumption rate was measured before and after the sequential addition of 2.5 µM oligomycin (ATP synthase inhibitor), cyanide p- (trifluoro-methoxy) phenyl-hydrazone (FCCP, uncoupler 0.5–3 µM) and 2.5/2.5 µM antimycin A/rotenone (complex III and I inhibitors, respectively). The non-mitochondrial oxygen consumption rate (obtained after the addition of antimycin A/rotenone) was subtracted from all measurements. Respiratory parameters were obtained as follows: basal (baseline OCR); ATP-independent (OCR resistant to the addition of oligomycin, proton leak); ATP-dependent (basal—ATP-independent); maximum (OCR obtained after the addition of FCCP); spare respiratory capacity (maximum—basal) [17 (link)]. Respiration was normalized considering cell number.
System minimization was performed in 3 cycles, with 1500, 2500, and 1500 steps for the ligand-free protein structures and for DPP III complexes with Leu-enkephalin and tynorphin, whereas for the complexes with Arg2-2NA and valorphin, for which X-ray structures are not available, an additional minimization cycle (4500 steps) was conducted without any constrains. In the first cycle, water molecules were relaxed while the rest of the system was harmonically restrained with a force constant of 32 kcal mol−1 Å−2. In the second and third cycles, the protein and peptide backbone atoms were restrained with force constants of 12 kcal mol−1 Å−2 and 6 kcal mol−1 Å−2, respectively.
The energy-optimized systems were heated to 300 K (30 ps, NVT ensemble), and the density was equilibrated (970 ps, NpT ensemble). The equilibrated systems were simulated for 1 μs under NpT conditions. During heating and equilibration, the time step was 1 fs, and during the productive MD simulations, it was 2 fs. The SHAKE algorithm was used to constrain covalent bonds with hydrogen atoms. The pressure was maintained at 1 atm using the Berendsen barostat [30 (link)], and the system temperature was kept constant at 300 K using the Langevin thermostat [31 (link)]. Simulations were performed using periodic boundary conditions (PBC) with a cutoff of 11 Å, and the particle mesh Ewald (PME) method was used to calculate long-range electrostatic interactions [32 (link),33 (link)]. Details of the MD simulations can be found in our previous publication [18 (link)]. To allow relaxation of the protein by binding a longer (hepta-peptide) ligand instead of a shorter one (penta-peptide), we restrained valorphin residues at the P2, P1, and P1’ positions and the protein residues E316, Y318, and H568 with the harmonic force constant of 32 kcal mol−1 Å−2 during heating, solvent density equilibration, and during 10 ns of MD simulations at 300 K of wild-type and mutant enzyme complexes’ MD simulations. Then, the systems were gradually relaxed in 4 series of 10 ns MD simulations at 300 K. In the first stage, the side chains of protein residues E316, Y318, and H568 were relaxed; in the second and third stages, the side chains of peptide residues P2, P1, and P1’ were also relaxed; in the fourth stage, only the backbone atoms of peptide residues P2, P1, and P1’ were restrained. These were followed by 1 μs of unconstrained MD simulations.
Top products related to «Electron Transport Complex III»
More about "Electron Transport Complex III"
This complex, often abbreviated as Complex III or ETC III, plays a central role in cellular respiration by catalyzing the oxidation of ubiquinol and the reduction of cytochrome c, thereby generating a proton gradient that drives ATP synthesis.
Research into the structure, function, and regulation of Electron Transport Complex III has implications for understanding energy metabolism, mitochondrial dysfunction, and various disease states.
The Oxygraph-2k is a powerful tool used to measure oxygen consumption rates, which can provide insights into the activity of Electron Transport Complex III.
Antimycin A, a specific inhibitor of Complex III, is often used in research to study its function and impact on cellular processes.
The XF24 Extracellular Flux Analyzer and the Seahorse XF Cell Mito Stress Test Kit are also valuable instruments that can be used to assess mitochondrial respiration, including the activity of Electron Transport Complex III.
Other key molecules and assays related to Electron Transport Complex III research include Oligomycin, which inhibits ATP synthase, and Rotenone, which inhibits Complex I of the electron transport chain.
The Seahorse XF24 Extracellular Flux Analyzer and the XF Cell Mito Stress Test Kit provide comprehensive tools for evaluating mitochondrial function and the role of Electron Transport Complex III.
Additionally, the Mitochondrial Complex III Activity Assay Kit offers a specific and reliable method for measuring the activity of this crucial complex.
PubCompare.ai's cutting-edge AI-driven protocol optimization can help researchers navigate the vast landscape of literature, pre-prints, and patents to uncover the best protocols and products for their Electron Transport Complex III research needs.
By seamlessly integrating these advanced tools and technologies, researchers can accelerate their discoveries and gain deeper insights into the essential role of Electron Transport Complex III in energy metabolism and mitochondrial function.